Editas Medicine, Inc. (EDIT)
1.82
+0.16
(+9.31%)
USD |
NASDAQ |
Feb 06, 16:00
1.83
+0.01
(+0.55%)
After-Hours: 20:00
Editas Medicine SG&A Expense (TTM) : 54.90M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| ADMA Biologics, Inc. | 96.37M |
| Arcutis Biotherapeutics, Inc. | 253.18M |
| Biogen, Inc. | 2.434B |
| Daré Bioscience, Inc. | 9.228M |
| Cogent Biosciences, Inc. | 51.34M |